The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo
Abstract
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human beta-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice. Upon glucose stimulation of the implanted mice, human insulin and C-peptide are detected in sera at levels similar to those of mice transplanted with approximately 3,000 human islets. Moreover, the insulin-expressing cells generated after engraftment exhibit many properties of functional beta-cells, including expression of critical beta-cell transcription factors, appropriate processing of proinsulin and the presence of mature endocrine secretory granules. Finally, in a test of therapeutic potential, we demonstrate that implantation of hES cell-derived pancreatic endoderm protects against streptozotocin-induced hyperglycemia. Together, these data provide definitive evidence that hES cells are competent to generate glucose-responsive, insulin-secreting cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, ViaCyte developed a stem cell-derived pancreatic endoderm cell population known as PEC-01, which they demonstrated to mature over several months in vivo into insulin-producing endocrine cells in rodent models.29–31”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [31]
Citations
Cites
Brissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Successful Islet Transplantation
Ryan, E. A., Lakey, J. R. T., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M., Bigam, D., Rajotte, R. V., & Shapiro, A. M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2148 · Cited by 719
Research works printed but not linked: 43
- Lakey, J.R., Mirbolooki, M. & Shapiro, A.M. Current status of clinical islet cell transplantation. Methods Mol. Biol. 333, 47–104 (2006).
- Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000). · DOI
- Rosler, E.S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259–274 (2004). · DOI
- D'Amour, K.A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005). · DOI · Paper page
- D'Amour, K.A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006). · DOI
- Jiang, J. et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25, 1940–1953 (2007). · DOI
- Tuch, B.E., Osgerby, K.J. & Turtle, J.R. Reversal of diabetes in hyperglycaemic nude mice by human fetal pancreas. Transplant. Proc. 21, 2665–2666 (1989).
- Beattie, G.M., Butler, C. & Hayek, A. Morphology and function of cultured human fetal pancreatic cells transplanted into athymic mice: a longitudinal study. Cell Transplant. 3, 421–425 (1994). · DOI
- Hayek, A. & Beattie, G.M. Experimental transplantation of human fetal and adult pancreatic islets. J. Clin. Endocrinol. Metab. 82, 2471–2475 (1997).
- Castaing, M. et al. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 44, 2066–2076 (2001). · DOI
- Castaing, M., Duvillie, B., Quemeneur, E., Basmaciogullari, A. & Scharfmann, R. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev. Dyn. 234, 339–345 (2005). · DOI
- Jensen, J. Gene regulatory factors in pancreatic development. Dev. Dyn. 229, 176–200 (2004). · DOI
- Zorn, A.M. & Wells, J.M. Molecular basis of vertebrate endoderm development. Int. Rev. Cytol. 259, 49–111 (2007). · DOI
- Jorgensen, M.C. et al. An illustrated review of early pancreas development in the mouse. Endocr. Rev. 28, 685–705 (2007). · DOI
- Gaber, A.O. et al. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant. Proc. 36, 1108–1110 (2004). · DOI
- Cabrera, O. et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA 103, 2334–2339 (2006). · DOI · Paper page
- Guz, Y. et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121, 11–18 (1995). · DOI
- Collombat, P. et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J. Clin. Invest. 117, 961–970 (2007). · DOI
- Olbrot, M., Rud, J., Moss, L.G. & Sharma, A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. USA 99, 6737–6742 (2002). · DOI
- Matsuoka, T.A. et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell. Biol. 23, 6049–6062 (2003). · DOI
- Matsuoka, T.A. et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl. Acad. Sci. USA 101, 2930–2933 (2004). · DOI
- Nishimura, W. et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 293, 526–539 (2006). · DOI
- Artner, I. et al. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 55, 297–304 (2006). · DOI
- Zhang, C. et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 25, 4969–4976 (2005). · DOI
- Wilson, M.E., Kalamaras, J.A. & German, M.S. Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech. Dev. 115, 171–176 (2002). · DOI
- Klimstra, D.S. in Histology for Pathologists. (ed. S.S. Sternberg) 613–647 (Lippincott-Raven Publishers, Philadelphia; 1997).
- Marzban, L. et al. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55, 2192–2201 (2006). · DOI
- Okamoto, H. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration. Biomed. Biochim. Acta 44, 15–20 (1985).
- Eizirik, D.L. et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc. Natl. Acad. Sci. USA 91, 9253–9256 (1994). · DOI
- Hosokawa, M., Dolci, W. & Thorens, B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem. Biophys. Res. Commun. 289, 1114–1117 (2001). · DOI
- Yang, H. & Wright, J.R., Jr. Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143, 2491–2495 (2002). · DOI
- Hering, B.J. et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. J. Am. Med. Assoc. 293, 830–835 (2005). · DOI
- Zertal-Zidani, S., Bounacer, A. & Scharfmann, R. Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans. Diabetologia 50, 585–595 (2007). · DOI
- Attali, M. et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 56, 1248–1258 (2007). · DOI
- Tulachan, S.S. et al. All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes 52, 76–84 (2003). · DOI
- Kobayashi, H. et al. Retinoid signaling controls mouse pancreatic exocrine lineage selection through epithelial-mesenchymal interactions. Gastroenterology 123, 1331–1340 (2002). · DOI
- Tuch, B.E. & Monk, R.S. Regulation of blood glucose to human levels by human fetal pancreatic xenografts. Transplantation 51, 1156–1160 (1991). · DOI
- Tuch, B.E., Jones, A. & Turtle, J.R. Maturation of the response of human fetal pancreatic explants to glucose. Diabetologia 28, 28–31 (1985). · DOI
- Tuch, B.E. Reversal of diabetes by human fetal pancreas. Optimization of requirements in the hyperglycemic nude mouse. Transplantation 51, 557–562 (1991). · DOI
- Fornoni, A. et al. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51, 298–308 (2008). · DOI
- Weitgasser, R., Davalli, A.M. & Weir, G.C. Measurement of glucose concentrations in rats: differences between glucose meter and plasma laboratory results. Diabetologia 42, 256 (1999). · DOI
- Joannides, A. et al. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24, 230–235 (2006). · DOI
- Schrot, R.J., Patel, K.T. & Foulis, P. Evaluation of inaccuracies in the measurement of glycemia in the laboratory, by glucose meters, and through measurement of hemoglobin A1c. Clin Diabetes 25, 43–49 (2007). · DOI
Cited by
Sorted by citations
Items 801–900 of 1,003
Jaramillo, M., Mathew, S., Task, K., Barner, S., & Banerjee, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094307 · Cited by 21
“The conclusion that WNT3A leads to better pancreatic differentiation potential is in agreement with a number of pancreatic differentiation studies that use WNT3A in combination with Activin A at the definitive endoderm stage, which have reported better yield, insulin expression and functionality after in vivo maturati…”
ResultMassumi, M., Hoveizi, E., Baktash, P., Hooti, A., Ghazizadeh, L., Nadri, S., Pourasgari, F., Hajarizadeh, A., Soleimani, M., Nabiuni, M., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.006 · Cited by 20
Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells
Knoepfler, P. S. (2012) · Regenerative Medicine · doi:10.2217/rme.12.51 · Cited by 24
Chen, C., Chai, J., Singh, L., Kuo, C.-Y., Jin, L., Feng, T., Marzano, S., Galeni, S., Zhang, N., Iacovino, M., et al. (2011) · Assay and drug development technologies · doi:10.1089/adt.2010.0314 · Cited by 20
“9 In addition, the expansive use of a number of recombinant proteins, such as Activin, wingless-int, fibroblast growth factor (FGF)10, and insulin-like growth factor, may be cost prohibitive for large-scale HTS projects.”
InfluentialHnf1α (MODY3) regulates β-cell-enriched MafA transcription factor expression.
Hunter, C. S., Maestro, M., Raum, J. C., Guo, M., Thompson, F., Ferrer, J., & Stein, R. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0362 · Cited by 20
Nestin Action During Insulin-secreting Cell Differentiation
Kim, S.-Y., Lee, S., Hong, S., Min, B., Lee, K.-U., Bendayan, M., & Park, I. (2010) · Journal of Histochemistry and Cytochemistry · doi:10.1369/jhc.2010.955682 · Cited by 20
Leung, K.-K., Suen, P.-M., Lau, T., Ko, W., Yao, K.-M., & Leung, P. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0325 · Cited by 20
“It is reasonable to expect our sPDZD2-treated ICCs, like other progenitor-derived cells in the pancreatic lineages, could be subjected to further functional maturation after transplantation in vivo [42,43].”
Melton, D. A. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2015.11.013 · Cited by 19
Bioreactor Systems for Tissue Engineering II
Kasper, C., van Griensven, M., & Pörtner, R. (2010) · Springer eBooks · doi:10.1007/978-3-642-16051-6 · Cited by 15
Stem cells and beta cell replacement therapy: a prospective health technology assessment study
Wallner, K., Pedroza, R. G., Awotwe, I., Piret, J. M., Senior, P. A., Shapiro, A. M. J., & McCabe, C. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0233-7 · Cited by 19
Stem cell therapies for diabetes
Chen, J. T., Dadheech, N., Tan, E. H. P., Ng, N. H. J., Koh, M., Shapiro, A. M. J., & Teo, A. K. K. (2025) · Nature Medicine · doi:10.1038/s41591-025-03767-8 · Cited by 26
“These cells were delivered in a macroencapsulation device designed to either be immunoprotective (product VC-01) or allow for direct vascularization of the PPs housed within the encapsulation device (VC-02) 18,19,49 .”
Huang, H., Bader, T., & Jin, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165867 · Cited by 21
“While previous studies have primarily focused on generating β-cells from stem cells or progenitors [2,3,85,86], paracrine regulation by the various islet hormones within intact islets is essential for maintaining physiological blood glucose regulation, which is principally mediated through the action of insulin on sto…”
BackgroundThe quest of cell surface markers for stem cell therapy
Meyfour, A., Pahlavan, S., Mirzaei, M., Krijgsveld, J., Baharvand, H., & Salekdeh, G. H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03602-y · Cited by 24
Komatsu, H., Gonzalez, N., Salgado, M., Cook, C. A., Li, J., Rawson, J., Omori, K., Tai, Y., KANDEEL, F. R., & Mullen, Y. (2020) · Transplant International · doi:10.1111/tri.13607 · Cited by 20
“Recent advancements in stem cell research have shed light on this treatment option for hematopoietic disorders (bone marrow transplantation) [1,2], peripheral nerve injury (Schwann-like cells) [3,4], and diabetes (beta cell transplantation) [5-7].”
BackgroundOhta, S., Ikemoto, T., Wada, Y., Saito, Y., Yamada, S., Imura, S., Morine, Y., & Shimada, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-55172-0 · Cited by 21
Xing, B.-H., Yang, F.-Z., & Wu, X.-H. (2016) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.04.014 · Cited by 19
20 years of Nature Biotechnology biomedical research
Azvolinsky, A., Schmidt, C. W., Waltz, E., & Webb, S. (2016) · Nature Biotechnology · doi:10.1038/nbt.3509 · Cited by 13
Nacher, M., Estil·les, E., García, A., Nadal, B., Pairó, M., Garcia, C. S., Secanella, L., Novials, A., & Montanya, E. (2016) · Cell Transplantation · doi:10.3727/096368915x688119 · Cited by 18
Chen, Y., Wang, X., & Shao, X. (2015) · Journal of Diabetes Research · doi:10.1155/2015/796912 · Cited by 16
Mi, Y., Guo, N., He, T.-Q., Ji, J., Li, Z., & Huang, P. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0100 · Cited by 19
A systems view of epigenetic networks regulating pancreas development and β‐cell function
Xie, R., Carrano, A. C., & Sander, M. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1287 · Cited by 23
Beneficial Effect of Insulin Treatment on Islet Transplantation Outcomes in Akita Mice
Kikawa, K., Sakano, D., Shiraki, N., Tsuyama, T., Kume, K., Endo, F., & Kume, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095451 · Cited by 19
Soggia, A., Flosseau, K., Ravassard, P., Szinnai, G., Scharfmann, R., & Guillemain, G. (2012) · Diabetologia · doi:10.1007/s00125-012-2623-0 · Cited by 19
Baiu, D. C., Merriam, F. V., & Odorico, J. S. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0218-7 · Cited by 20
Directed embryonic stem cell differentiation with small molecules.
Zhu, S.-T., Wurdak, H., & Schultz, P. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.190 · Cited by 19
Lineage-specific reprogramming as a strategy for cell therapy
Darabi, R., & Perlingeiro, R. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6159 · Cited by 19
Bose, B., & Sudheer, P. (2016) · Methods in molecular biology · doi:10.1007/7651_2015_230 · Cited by 19
Borowiak, M. (2010) · The Review of Diabetic Studies · doi:10.1900/rds.2010.7.93 · Cited by 20
“1, when injected into mice tissue can give rise to glucoseresponsive, insulin-secreting cells after several weeks of in vivo maturation [44, 46].”
BackgroundBone marrow stem cell-derived β-cells: New issue for diabetes cell therapy.
Aglan, H., Kotob, S. E., Mahmoud, N., Kishta, M., & Ahmed, H. H. (2023) · Tissue & Cell · doi:10.1016/j.tice.2023.102280 · Cited by 18
Braam, M., Zhao, J., Liang, S., Ida, S., Kloostra, N. K., Iworima, D., Tang, M., Baker, R. K., Quiskamp, N., Piret, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35716-1 · Cited by 18
Ma, X.-J., Cao, J., Zhou, Z.-Y., Lu, Y.-K., Li, Q. H., Jin, Y., Chen, G., Wang, W.-Y., Ge, W., Chen, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31698-2 · Cited by 18
Le, Q. D., Rodprasert, W., Kuncorojakti, S., Pavasant, P., Osathanon, T., & Sawangmake, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-13114-3 · Cited by 22
Liu, S.-Y., Yang, R.-J., Yin, N.-Y., & Faiola, F. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126709 · Cited by 18
Tan, M., Jiang, L., Li, Y., & Jiang, W. (2019) · Stem Cells International · doi:10.1155/2019/5026793 · Cited by 23
“NOGGIN, as a well-recognized BMP antagonist, has been broadly used in previous protocols [4, 5, 8] and effectively directed pancreatic differentiation.”
BackgroundInfluentialMesodermal induction of pancreatic fate commitment
Seymour, P. A., & Serup, P. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.08.008 · Cited by 18
Zhang, S.-Y., & Shi, B.-L. (2017) · BioMed Research International · doi:10.1155/2017/6352858 · Cited by 18
“Additionally, with developing technologies of cell culture and genetic engineering [13, 14], the therapeutic effects of MSC could be further promoted via integrating other wellestablished methods in vivo [15, 16] and in clinic [17], overcoming the serious side effects caused by clinical practice of monotherapy [18].”
BackgroundTomov, M. L., Olmsted, Z. T., Dogan, H., Gongorurler, E., Tsompana, M., Otu, H. H., Buck, M. J., Chang, E.-A., Cibelli, J. B., & Paluh, J. L. (2016) · Scientific Reports · doi:10.1038/srep37637 · Cited by 19
Monitoring of allogeneic islet grafts in nonhuman primates using magnetic resonance imaging
Wang, P., Schuetz, C., Vallabhajosyula, P., Medarova, Z., Tena, A., Wei, L., Yamada, K., Deng, S., Markmann, J., Sachs, D., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000682 · Cited by 18
“Recent seminal study by Kroon et al(31) and Rezania et al(32) demonstrated successful application of human embryonic stem cell–derived pancreatic progenitors for restoring normoglycemia.(31) First phase clinical trials using this approach are currently underway.”
BackgroundThe Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases
Hew, M., O’Connor, K. D. J., Edel, M. J., & Lucas, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4061193 · Cited by 21
“cells derived from human embryonic stem cells have been able to secrete insulin, and maintain normoglycaemia in a murine model of induced diabetes up until the grafts are removed [42].”
BackgroundHoveizi, E., Massumi, M., Ebrahimi-Barough, S., Tavakol, S., & Ai, J. (2015) · Cell Biology International · doi:10.1002/cbin.10430 · Cited by 18
Dominant and context-specific control of endodermal organ allocation by Ptf1a
Willet, S. G., Hale, M. A., Grapin‐Botton, A., Magnuson, M. A., MacDonald, R. J., & Wright, C. V. E. (2014) · Development · doi:10.1242/dev.114165 · Cited by 19
Pereyra-Bonnet, F., Gimeno, M., Argumedo, N. R., Ielpi, M., Cardozo, J. A., Giménez, C. A., Hyon, S., Balzaretti, M., Loresi, M., Fainstein-Day, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100369 · Cited by 18
“Finally, many of the hormone-positive in vitro cells that were obtained here co-express glucagon, insulin and somatostatin, as shown previously [2,35], which indicates a polyhormonal immature in vitro state.”
BackgroundPandian, G., Taniguchi, J., & Sugiyama, H. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-6 · Cited by 18
“For example, some of the currently available reprogramming protocols harbor the risk of transgene integration and mutagenesis, which are not clinical friendly [29].”
BackgroundHe, K., Juhl, K., Karadimos, M. J., Khattabi, I. E., Fitzpatrick, C., Bonner-Weir, S., & Sharma, A. J. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.10.024 · Cited by 18
“Yet differentiation protocols for deriving functional β-cells from embryonic stem (ES) cells and induced pluripotent stem (iPS) cells (D’Amour et al., 2006; Kroon et al., 2008; Maehr et al., 2009; McKnight et al., 2010; Rezania et al., 2012) still only result in immature cells with limited insulin content and lacking…”
BackgroundRicordi, C., Inverardi, L., & Domínguez‐Bendala, J. (2012) · Regenerative Medicine · doi:10.2217/rme.12.70 · Cited by 16
Wang, A., & Sander, M. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0923-y · Cited by 19
“involves in vivo engraftment of these cells into mice [27].”
BackgroundInfluentialOxidative stress-induced biomarkers for stem cell-based chemical screening
Yang, S., Rahman, I., Trosko, J. E., & Kang, K. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.11.013 · Cited by 20
Turovets, N., Fair, J., West, R., Ostrowska, A., Semechkin, R., Janus, J., Cui, L., Agapov, V., Turovets, I., Semechkin, A., et al. (2012) · Cell Transplantation · doi:10.3727/096368911x582723 · Cited by 18
Differentiation into Endoderm Lineage: Pancreatic differentiation from Embryonic Stem Cells
Lee, D. H., & Chung, H. (2011) · International Journal of Stem Cells · doi:10.15283/ijsc.2011.4.1.35 · Cited by 26
“A stepwise protocol directing human ES cell differentiation were developed, which entails differentiation processes that recapitulates the major stages of normal pancreatic endocrine development (4, 5, 36, 37).”
BackgroundMethodInfluentialShao, S., Gao, Y., Xie, B., Xie, F., Lim, S. K., & Li, G.-D. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0378 · Cited by 18
“Indeed, hyperinsulinemia and hypoglycemia were also seen in animals transplanted with neonatal islet cells (Aguayo-Mazzucato et al. 2006) and hES cell-derived endocrine cells (Kroon et al. 2008).”
Fukumitsu, K., Ishii, T., Yasuchika, K., Amagai, Y., Kawamura-Saito, M., Kawamoto, T., Kawase, E., Suemori, H., Nakatsuji, N., Ikai, I., et al. (2009) · Tissue Engineering. Part A · doi:10.1089/ten.tea.2009.0357 · Cited by 18
Ravassard, P., Bricout-Neveu, E., Hazhouz, Y., Pechberty, S., Mallet, J., Czernichow, P., & Scharfmann, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004731 · Cited by 18
“However, mass production of pure beta cells could not be achieved with such process [19].”
BackgroundMarchand, M., Schroeder, I., Markossian, S., Skoudy, A., Nègre, D., Cosset, F., Real, P., Kaiser, C., Wobus, A., & Savatier, P. (2009) · International Journal of Developmental Biology · doi:10.1387/ijdb.092856mm · Cited by 18
Get with the (re)program: cardiovascular potential of skin-derived induced pluripotent stem cells.
Tulloch, N., Pabon, L., & Murry, C. (2008) · Circulation · doi:10.1161/circulationaha.108.791442 · Cited by 18
Rolletschek, A., Schroeder, I., Schulz, H., Hummel, O., Huebner, N., & Wobus, A. (2010) · International Journal of Developmental Biology · doi:10.1387/ijdb.082694ar · Cited by 18
Development of insulin-producing cells from primitive biologic precursors
Evans-Molina, C., Vestermark, G. L., & Mirmira, R. G. (2009) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283186fc1 · Cited by 18
Wong, J. M., & Pepper, A. R. (2024) · Frontiers in Transplantation · doi:10.3389/frtra.2024.1485444 · Cited by 19
Merz, S. K., Breunig, M., Melzer, M. K., Heller, S., Wiedenmann, S., Seufferlein, T. T. W., Meier, M., Krüger, J., Mulaw, M. A., Hohwieler, M., et al. (2023) · Theranostics · doi:10.7150/thno.78323 · Cited by 22
“However, based on our and other’s previous efforts, transplantation of any PPs into an in vivo niche is likely to bypass limitations of in vitro protocols and usually properly generates all three lineages [7, 29, 44, 45].”
BackgroundPerspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies
Wiśniewska, J., Sadowska, A., Wójtowicz, A., Słyszewska, M., & Szóstek-Mioduchowska, A. Z. (2021) · Life · doi:10.3390/life11101068 · Cited by 20
“It is estimated that teratomas develop in 33–100% of hESCtransplanted immunodeficient mice [261,262].”
BackgroundThe functional importance of the cellular and extracellular composition of the islets of Langerhans
Wieland, F. C., van Blitterswijk, C., van Apeldoorn, A. A., & LaPointe, V. L. S. (2021) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2021.100048 · Cited by 18
Felix dies natalis, insulin… ceterum autem censeo “beta is better”
Piemonti, L. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01737-3 · Cited by 18
Tang, S., Zhang, M., Zeng, S., Huang, Y., Qin, M., Nasri, U., Santamaría, P., Riggs, A. D., Jin, L., & Zeng, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012389117 · Cited by 19
“We should point out that bihormonal InsulinGlucagon β cells can be immature β cells at a transitional stage (63) or dysfunctional (28).”
BackgroundEngineered Biomaterials for Enhanced Function of Insulin‐Secreting β‐Cell Organoids
Hunckler, M. D., & García, A. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000134 · Cited by 24
Mochida, T., Ueno, H., Tsubooka-Yamazoe, N., Hiyoshi, H., Ito, R., Matsumoto, H., & Toyoda, T. (2020) · Diabetes · doi:10.2337/db19-0728 · Cited by 17
T3 Induces Both Markers of Maturation and Aging in Pancreatic β-Cells
Aguayo‐Mazzucato, C., Lee, T. B., Matzko, M. E., DiIenno, A. R., Rezanejad, H., Ramadoss, P., Scanlan, T. S., Zavacki, A. M., Larsen, P. R., Hollenberg, A. N., et al. (2018) · Diabetes · doi:10.2337/db18-0030 · Cited by 18
“hESC Differentiation Protocol We followed the Viacyte surface-attached b-cell differentiation protocol (24,25) with the following modifications: 1) Matrigel-coated silicon rubber as the surface on which hESCs (CyT49) were plated, 2) stage 3 lengthened to 7 days, and 3) a 3-day stage 5 with DMEM-B27 media and 100 pmol/…”
MethodJiang, Y., Zhang, W., Xu, S., Lin, H. V., Sui, W., Liu, H., Peng, L., Fang, Q., Chen, L., & Lou, J. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1253-1 · Cited by 16
“The findings were similar to those of previous reports [14, 26].”
ResultSaitoh, I., Sato, M., Soda, M., Inada, E., Iwase, Y., Murakami, T., Ohshima, H., Hayasaki, H., & Noguchi, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163580 · Cited by 17
Faleo, G., Lee, K., Nguyen, V., & Tang, Q. (2016) · Transplantation · doi:10.1097/tp.0000000000001146 · Cited by 17
Boost for Alginate Encapsulation in Beta Cell Transplantation
PIPELEERS, D. G., & Keymeulen, B. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.03.010 · Cited by 20
“A major step towards a large source of candidate donor cells was achieved by driving the differentiation of hESC into pancreatic progenitor cells that form insulin-producing implants in mice [3], and that can be further directed to beta cells in vitro [4,5] (Figure 1).”
BackgroundZhao, Q., Yang, Y., Hu, J. R., Shan, Z., Wu, Y., & Lei, L. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.57596 · Cited by 16
Santosa, M. M., Low, B. S. J., Pek, N. M. Q., & Teo, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00194 · Cited by 17
The cell cycle as a brake for β-cell regeneration from embryonic stem cells
El-Badawy, A., & El‐Badri, N. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0274-z · Cited by 14
“Recent studies have shown, however, that pancreatic endoderm cells derived from human ES (hES) cells can produce insulin in response to glucose several months after transplantation into immunodeficient mice [19].”
BackgroundResultLi, X.-L., Gan, K.-X., Song, G., & Wang, C. (2015) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2015.04.018 · Cited by 17
Inhibition of ZEB1 expression induces redifferentiation of adult human β cells expanded in vitro
Sintov, E., Nathan, G., Knoller, S., Pasmanik-Chor, M., Russ, H., & Efrat, S. (2015) · Scientific Reports · doi:10.1038/srep13024 · Cited by 17
Willems, C., & Vankelecom, H. (2014) · Regenerative medicine · doi:10.2217/rme.14.19 · Cited by 17
Zhou, Y., Mack, D. L., Williams, J. K., Mirmalek-Sani, S.-H., Moorefield, E., Chun, S.-Y., Wang, J., Lorenzetti, D., Furth, M. E., Atala, A., et al. (2013) · Cells Tissues Organs · doi:10.1159/000345816 · Cited by 16
Development and Regeneration in the Endocrine Pancreas
Mansouri, A. (2012) · ISRN Endocrinology · doi:10.5402/2012/640956 · Cited by 16
“Analyses of knockout mice lacking factors implicated in pancreas development have made the path for the establishment of protocols to generate insulin-producing cells from progenitor and/or embryonic stem cells [34].”
BackgroundStem Cell-Based Therapies: Promises, Obstacles, Discordance, and the Agora
Eggleson, K. K. (2012) · Perspectives in biology and medicine · doi:10.1353/pbm.2012.0001 · Cited by 10
“Interestingly, it seems that I² cells do not fully mature in vitro, and that in vivo niche factors are essential for the final steps of the process (”
BackgroundTreatment of diabetes by transplantation of drug-inducible insulin-producing gut cells
Unniappan, S., Wideman, R., Donald, C., Gunn, V., Wall, J., Zhang, Q.-X., Webber, T. D., Cheung, A., & Kieffer, T. (2009) · Journal of molecular medicine · doi:10.1007/s00109-009-0465-0 · Cited by 17
“Thus, even the current “gold standard” for transplant-based approaches to treating type 1 diabetes can cause hypoglycemia in mice, perhaps due to the lower homeostatic “set point” of human insulinproducing cells compared to rodents [ 4 ], and/or to underestimation of rodent blood glucose levels by handheld glucometers…”
BackgroundEpigenetics in Allergy and Autoimmunity
Chang, C., Editors, Q. L., Crusio, W. E., Lambris, J. D., & Lu, Q.-J. (2020) · doi:10.1007/978-981-15-3449-2 · Cited by 17
Solving the Puzzle of Immune Tolerance for β-Cell Replacement Therapy for Type 1 Diabetes
Bluestone, J. A., & Tang, Q. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.008 · Cited by 16
The Last Mile in Beta-Cell Replacement Therapy for Type 1 Diabetes: Time to Grow Up
Piemonti, L. (2025) · Transplant International · doi:10.3389/ti.2025.14565 · Cited by 16
“The successful differentiation of stem cell-derived beta-like cells — whether from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) — into insulin-producing cells suitable for transplantation represents a paradigm shift [18 – 23].”
Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors
Fontcuberta-PiSunyer, M., García-Alamán, A., Prades, È., Téllez, N., Alves-Figueiredo, H., Ramos-Rodríguez, M., Enrich, C., Fernández-Ruiz, R., Cervantes, S., Clua, L., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04627-2 · Cited by 16
Recent advances in deriving human endodermal tissues from pluripotent stem cells.
Kechele, D. O., & Wells, J. M. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.009 · Cited by 16
Generation of Human Stem Cell-Derived Pancreatic Organoids (POs) for Regenerative Medicine
Navarro‐Tableros, V., Gomez, Y., Brizzi, M. F., & Camussi, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_340 · Cited by 17
Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
Nijhoff, M. F., & de Koning, E. J. P. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1073-6 · Cited by 19
Miyagi-Shiohira, C., Nakashima, Y., Kobayashi, N., Saitoh, I., Watanabe, M., & Noguchi, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-30784-0 · Cited by 16
Millette, K., & Georgia, S. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0947-3 · Cited by 18
Kimura, A., Toyoda, T., Nishi, Y., Nasu, M., Ohta, A., & Osafune, K. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.08.010 · Cited by 20
Liu, H., Guo, D., Ruzi, A., Chen, Y., Pan, T., Yang, F., Li, J., Xu, K., Zhou, T., Qin, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179353 · Cited by 17
Beneath The Sword Of Damocles: Regenerative Medicine And The Shadow Of Immunogenicity
Fairchild, P. J., Horton, C. G., Lahiri, P., Shanmugarajah, K., & Davies, T. J. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0134 · Cited by 17
Is Transforming Stem Cells to Pancreatic Beta Cells Still the Holy Grail for Type 2 Diabetes?
Kahraman, S., Okawa, E. R., & Kulkarni, R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0764-0 · Cited by 16
Molecular causes of transcriptional response: a Bayesian prior knowledge approach
Zarringhalam, K., EnayetAllah, A. E., Gutteridge, A., Sidders, B. S., & Ziemek, D. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt557 · Cited by 14
Fryer, B. H., Rezania, A., & Zimmerman, M. C. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835edb4c · Cited by 14
Kim, J. H., Park, S.-J., Hm, K., Ahn, C., Hc, K., Song, J.-W., Yj, L., Lee, K., Yang, H., Sy, B., et al. (2012) · Cell Transplantation · doi:10.3727/096368912x636803 · Cited by 16
“Indeed, many studies observed the presence of human insulin and/or c-peptide in the blood of recipient that has recovered from hyperglycemia following human cell transplantation (23,26,44,45).”
BackgroundInfluentialFishman, B., Segev, H., Kopper, O., Nissenbaum, J., Schulman, M., Benvenisty, N., Itskovitz-Eldor, J., & Kitsberg, D. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9363-x · Cited by 16
Schroeder, I., Sulzbacher, S., Nolden, T., Fuchs, J., Czarnota, J., Meisterfeld, R., Himmelbauer, H., & Wobus, A. (2011) · Cells Tissues Organs · doi:10.1159/000329864 · Cited by 16
“…et al., 2007], (4) the differentiation via multilineage progenitors [Blyszczuk et al., 2004; Schroeder et al., 2006], (5) the use of conditioned medium from fetal pancreatic buds [Vaca et al., 2006] and (6) the selection and enrichment of a nestin-expressing cell population [Lumelsky et al., 2001].”
BackgroundMethodResultInfluentialLi, B.-W., Wang, S.-H., Liu, H., Liu, D.-Q., Zhang, J., Zhang, B., Yao, H., Lv, Y., Wang, R.-Y., Chen, L., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0195 · Cited by 16
“Recent studies have shown that insulin-secreting cells can be generated from embryonic stem cells [2], induced pluripotent stem cells [3], or adult stem cells [4].”
Cellular reprogramming of human amniotic fluid cells to express insulin.
Gage, B. K., Riedel, M. J., Karanu, F., Rezania, A., Fujita, Y., Webber, T. D., Baker, R. K., Wideman, R., & Kieffer, T. (2010) · Differentiation; research in biological diversity · doi:10.1016/j.diff.2010.05.007 · Cited by 16
Appl1 is essential for the survival of Xenopus pancreas, duodenum, and stomach progenitor cells
Wen, L., Yang, Y., Wang, Y., Xu, A., Wu, D.-H., & Chen, Y.-L. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22356 · Cited by 16
“So far, the differentiation and maturation of human embryonic stem cells into functional beta cells requires unknown factors that can be provided by an in vivo environment (Kroon et al., 2008).”
Background
Metadata
- Authors
- Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., Agulnick, A. D., D'Amour, K. A., Carpenter, M. K., & Baetge, E. E.
- Venue
- Nature Biotechnology
- Published
- 2008-02-20
- Volume
- 26
- Issue
- 4
- Pages
- 443-452
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2106219965
- Cited by
- 1,843
- References
- 0
- Citations by year
- 2026: 26 · 2025: 44 · 2024: 46 · 2023: 88 · 2022: 67 · 2021: 81 · 2020: 85 · 2019: 76 · 2018: 87 · 2017: 98 · 2016: 122 · 2015: 116 · 2014: 156 · 2013: 168 · 2012: 154
- FWCI
- 150.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- human embryonic stem cells, beta cell differentiation, glucose-dependent insulin secretion, islet transplantation, diabetes cell therapy, C-peptide, proinsulin processing, streptozotocin-induced hyperglycemia
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Endoderm, Glucose, Humans, Insulin, Cell Culture Techniques, Pancreas, Artificial, Tissue Engineering, Cell Proliferation, Insulin-Secreting Cells, Mice, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review